Cimeio Therapeutics is an applied gene editing, cellular, and immunotherapy company developing a portfolio of Shielded-Cell & Immunotherapy Pairs for patients with serious and life-threatening diseases.

Biotechnology

Cimeio Therapeutics

Thomas Fuchs

Tanja Herrmann

Saniye Yumlu

Florence Widmann

Stefanie Urlinger

Rosalba Lepore

Thomas Winkler

Daniel Stark

Lukas Jeker

Tristan Imbert

The Leadership Team at Cimeio Therapeutics steers the company’s strategic direction and operational execution in developing advanced gene editing and immunotherapy solutions. Comprised of experts in manufacturing, scientific research, medical strategy, and finance, this team collaborates to drive innovation, ensure compliance with regulatory standards, and maximize clinical and commercial success in addressing serious and life-threatening diseases.

Leadership Team

Scientific Research and Development

Board Members

Leadership Team

About

Team members

Other teams at Cimeio Therapeutics

Scientific Research and Development

Board Members